Cite
MLA Citation
Yuankai Shi et al.. “Comparison of efficacy and safety of ripertamab (SCT400) versus rituximab (Mabthera®) in combination with CHOP in patients with previously untreated CD20‐positive diffuse large B‐cell lymphoma: A randomized, single‐blind, phase III clinical trial.” Hematological oncology, vol. 40, no. 5, 2022, pp. 930–940. http://access.bl.uk/ark:/81055/vdc_100172222046.0x000045